Overview

A 4-Day Study to Evaluate the Photoxicity of Diacerein 1% Topical Ointment in Healthy Volunteers

Status:
Completed
Trial end date:
2017-12-15
Target enrollment:
Participant gender:
Summary
This study was designed to assess the phototoxic potential of diacerein 1% ointment when application is followed by light exposure.
Phase:
Phase 1
Details
Lead Sponsor:
Castle Creek Pharmaceuticals, LLC
Treatments:
Diacetylrhein